Form 4 for INCY Incyte
Accepted 2024-07-17 00:00:00 ET · period of report 2024-07-15 · accession 0000879169-24-000139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-17 | 2024-07-15 | INCY | Stein Steven H | EVP, Chief Medical Off | F - Tax | $64.25 | -1,555 | 101.6K | -2% | -$99.9K |
| D | 2024-07-17 | 2024-07-15 | INCY | Stein Steven H | EVP, Chief Medical Off | A - Grant | $0.00 | +13.9K | 103.2K | +16% | $0 |
| D | 2024-07-17 | 2024-07-15 | INCY | Stein Steven H | EVP, Chief Medical Off | A - Grant | $0.00 | +31.1K | 31.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-15 | F | D | 1,555 | $64.25 | 101,619 | D | — | — | (F2) Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. (F3) Including the July 15, 2024 grant, this includes an aggregate of 87,452 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. |
| 2 | Common | Common Stock | 2024-07-15 | A | A | 13,895 | $0.00 | 103,174 | D | — | — | (F1) Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-07-15 | A | A | 31,088 | $0.00 | 31,088 | D | $64.25 · — to 2034-07-14 | 31,088 Common Stock | (F4) The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |